These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22528515)

  • 21. D2-40-positive lymphatic vessel density is a poor prognostic factor in squamous cell carcinoma of the lung.
    Iwakiri S; Nagai S; Katakura H; Takenaka K; Date H; Wada H; Tanaka F
    Ann Surg Oncol; 2009 Jun; 16(6):1678-85. PubMed ID: 19330380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression and significance of E-cadherin, CD44v6, and proliferating cell nuclear antigen in non-small cell lung cancer].
    Weng MX; Wu CH; Yang XP
    Ai Zheng; 2008 Feb; 27(2):191-5. PubMed ID: 18279620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer.
    Sulzer MA; Leers MP; van Noord JA; Bollen EC; Theunissen PH
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1319-23. PubMed ID: 9563756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
    Adachi Y; Nakamura H; Kitamura Y; Taniguchi Y; Araki K; Shomori K; Horie Y; Kurozawa Y; Ito H; Hayashi K
    Pathol Int; 2007 Apr; 57(4):171-7. PubMed ID: 17316411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression and significance of integrin alpha5, beta1 and E-CD in patients with non-small cell lung carcinoma].
    Guo QS; Jia H; Han MY; Yu JM; Zhong WX
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):746-9. PubMed ID: 17366785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of peritumoral lymphatic vessel density and lymphatic vessel invasion detected by D2-40 immunostaining in FIGO Ib1-IIa squamous cell cervical cancer.
    Xiong Y; Cao LP; Rao HL; Cai MY; Liang LZ; Liu JH
    Cell Tissue Res; 2012 Jun; 348(3):515-22. PubMed ID: 22492093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can lymphatic vascular density be used in determining metastatic spreading potential of tumor in invasive ductal carcinomas?
    Kandemir NO; Barut F; Bektas S; Ozdamar SO
    Pathol Oncol Res; 2012 Apr; 18(2):253-62. PubMed ID: 21785902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer.
    Shiwu WU; Lan Y; Wenqing S; Lei Z; Yisheng T
    Arch Iran Med; 2012 Nov; 15(11):707-12. PubMed ID: 23102249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between expression of cell adhesion molecules CD₄₄ v6 and E-cadherin and lymphatic metastasis in non- small cell lung cancer.
    Su CY; Li YS; Han Y; Zhou SJ; Liu ZD
    Asian Pac J Cancer Prev; 2014; 15(5):2221-4. PubMed ID: 24716905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological significance and prognostic value of E-cadherin expression in non-small cell lung cancer: A protocol for systematic review and meta-analysis.
    Chao D; Hu G; Li Q
    Medicine (Baltimore); 2021 Feb; 100(7):e24748. PubMed ID: 33607820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
    Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer.
    Bremnes RM; Veve R; Gabrielson E; Hirsch FR; Baron A; Bemis L; Gemmill RM; Drabkin HA; Franklin WA
    J Clin Oncol; 2002 May; 20(10):2417-28. PubMed ID: 12011119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. delta-Catenin promotes malignant phenotype of non-small cell lung cancer by non-competitive binding to E-cadherin with p120ctn in cytoplasm.
    Zhang JY; Wang Y; Zhang D; Yang ZQ; Dong XJ; Jiang GY; Zhang PX; Dai SD; Dong QZ; Han Y; Zhang S; Cui QZ; Wang EH
    J Pathol; 2010 Sep; 222(1):76-88. PubMed ID: 20593408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of vascular endothelial growth factor C and cyclooxygenase-2 in non-small-cell lung carcinoma and their clinical significance].
    Zhang HZ; Hua P; Li HG; Lü ZQ; Zeng YJ; Liu JG; Zeng H
    Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):734-7. PubMed ID: 16483484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inverse correlation of S100A4 and E-cad protein expression and their clinical significance in non-small cell lung cancer].
    Qi RX; Xu XY
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):681-4. PubMed ID: 18246798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphatic microvessel density using D2-40 is associated with nodal metastasis in non-small cell lung cancer.
    Takanami I
    Oncol Rep; 2006 Feb; 15(2):437-42. PubMed ID: 16391866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
    Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS
    Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma.
    Lee K; Park DJ; Choe G; Kim HH; Kim WH; Lee HS
    Ann Surg Oncol; 2010 Jan; 17(1):73-80. PubMed ID: 19777179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of E-cadherin in lung carcinoma, other than those with small cells (NSCLC).
    Grigoraş ML; Arghirescu TS; Folescu R; Talpoş IC; Gîndac CM; Zamfir CL; Cornianu M; Anghel MD; Levai CM
    Rom J Morphol Embryol; 2017; 58(4):1317-1325. PubMed ID: 29556623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of CASS4 promotes invasion in non-small cell lung cancer by activating the AKT signaling pathway and inhibiting E-cadherin expression.
    Li A; Zhang W; Xia H; Miao Y; Zhou H; Zhang X; Dong Q; Li Q; Qiu X; Wang E
    Tumour Biol; 2016 Nov; 37(11):15157-15164. PubMed ID: 27677288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.